Your browser doesn't support javascript.
loading
Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine.
van der Schaar, J A J; Attema-de Jonge, M E; Gresnigt, F M J; Franssen, E J F.
Affiliation
  • van der Schaar JAJ; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.
  • Attema-de Jonge ME; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.
  • Gresnigt FMJ; Emergency Department, OLVG, Amsterdam, The Netherlands.
  • Franssen EJF; Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.
Toxicol Rep ; 7: 539-546, 2020.
Article in En | MEDLINE | ID: mdl-32368504
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Language: En Journal: Toxicol Rep Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Language: En Journal: Toxicol Rep Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Ireland